Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 47

Sort by

Sort Order Select

Journal Articles

26S Proteasome Non-Atpase Subunit 3 (PSMD3/Rpn3) Is a Potential Therapeutic Target in Multiple Myeloma

Teng Fang, Yan Song, Ting Du, Arghya Ray, Xueping Wan, Minxing Wang, Sindhu C Pillai, Md. Abu Musa, Mu Hao, Lugui Qiu, Dharminder Chauhan, Kenneth C. Anderson

Blood (2024) 144 (Supplement 1): 1905.

https://doi.org/10.1182/blood-2024-206000

Published: 2024

Journal Articles

Synergistic Induction of Senescence-Driven Immune Responses and Myeloma Cell Cytotoxicity By CDK4/6 Inhibitors and Daratumumab Combination Therapy

Shiyi Xie, Zhen Yu, Mu Hao, Lu-Gui Qiu, Mariateresa Fulciniti, Nikhil C. Munshi, Yan Xu

Blood (2024) 144 (Supplement 1): 1410.

https://doi.org/10.1182/blood-2024-200479

Published: 2024

Journal Articles

TENT5C As a Target of Chromatin Remodeler SMARCA2 Participates BTK Inhibitor Resistance in Mantle Cell Lymphoma By Regulating ATP Metabolism

Yuting Yan, Dandan Shan, Ying Yu, Weihao Chen, Xinyi Zhang, Xiong Wenjie, Tingyu Wang, Mu Hao, Gang An, Lu-Gui Qiu, Zhen Yu, Shuhua Yi

Blood (2024) 144 (Supplement 1): 832.

https://doi.org/10.1182/blood-2024-201941

Published: 2024

Journal Articles

Single-Cell RNA Analysis of Bone Marrow Mononuclear Cells Reveals Abnormal Activation of T Cells and Monocytes, and Identifies CD35 As a Novel Biomarker and Therapeutic Target in Waldenstrom Macroglobulinemia

Hao Sun, Xia Liu, Maria Luisa Guerrera, Nickolas Tsakmaklis, Amanda Kofides, Andres Felipe Ramirez Gamero, Catherine A. Flynn, Christopher J Patterson, Mu Hao, Lugui Qiu, Shayna R Sarosiek, Jorge J. Castillo, Zachary R Hunter, Shirong Liu, Steven P. Treon

Blood (2024) 144 (Supplement 1): 743.

https://doi.org/10.1182/blood-2024-211488

Published: 2024

Journal Articles

Critical Roles of LILRB4 in Promoting PIM Kinase Mediated Cell Proliferation and Tumorigenesis in Multiple Myeloma

Yijie Wang, Jingyuan Ma, Xiyue Sun, Lixin Gong, Lanting Liu, Gang An, Lu-Gui Qiu, Mu Hao

Blood (2024) 144 (Supplement 1): 3262.

https://doi.org/10.1182/blood-2024-202920

Published: 2024

Journal Articles

Genomic Evolution By Serial Single-Cell Sequencing Identifies High Tumor Expression of LYN As a Promoter of Resistance in Waldenstrom's Macroglobulinemia Undergoing Ibrutinib Monotherapy

Hao Sun, Romanos Sklavenitis-Pistofidis, Xia Liu, Nickolas Tsakmaklis, Maria Luisa Guerrera, Amanda Kofides, Andres Felipe Ramirez Gamero, Catherine A. Flynn, Christopher J Patterson, Mu Hao, Lu-Gui Qiu, Shayna R Sarosiek, Jorge J. Castillo, Zachary R Hunter, Shirong Liu, Steven P. Treon

Blood (2024) 144 (Supplement 1): 4338.

https://doi.org/10.1182/blood-2024-211597

Published: 2024

Journal Articles

Determination of MYD88 and CXCR4 Mutation for Clinical Detection and Their Significance in Waldenström Macroglobulinemia

Blood (2024) 144 (Supplement 1): 4349.

https://doi.org/10.1182/blood-2024-202324

Published: 2024

Journal Articles

A Novel Indirubin-3-Monoxime Derivative Enhance Immune Cell Mediated Cytotoxicity in Multiple Myeloma

Xiaoyu Zhang, Xiyue Sun, Lanting Liu, Zhen Yu, Lu-Gui Qiu, Mu Hao

Blood (2024) 144 (Supplement 1): 7467.

https://doi.org/10.1182/blood-2024-202892

Published: 2024

Journal Articles

Single-Cell Multi-Omics Analysis Reveals Heterogeneity of Malignant Plasma Cell during Progression of Multiple Myeloma

Fangshuo Feng, Hao Sun, Xiaoyu Zhang, Xiyue Sun, Tengteng Yu, Haiqing Xiong, Gang An, Lu-Gui Qiu, Mu Hao

Blood (2024) 144 (Supplement 1): 6845.

https://doi.org/10.1182/blood-2024-203100

Published: 2024

Journal Articles

Clinical Implications of Residual Immunophenotypically Normal Plasma Cells within Bone Marrow at Various Disease Stages in Multiple Myeloma

Wenqiang Yan, Lihui Shi, Jingyu Xu, Lingna Li, Jian Cui, Chenxing DU, Tengteng Yu, Shuaishuai Zhang, Rui Lv, Weiwei Sui, Shuhui Deng, Yan Xu, Dehui Zou, Lu-Gui Qiu, Mu Hao, Gang An

Blood (2024) 144 (Supplement 1): 1932.

https://doi.org/10.1182/blood-2024-199452

Published: 2024

Journal Articles

TRIM28 Serves As a Key Regulator of Protein Homeostasis and Mediates Proteasome Inhibitor Resistance in Multiple Myeloma

Teng Fang, Lanting Liu, Hao Sun, Xiyue Sun, Zhen Yu, Lugui Qiu, Mu Hao

Blood (2024) 144 (Supplement 1): 4668.

https://doi.org/10.1182/blood-2024-204159

Published: 2024

Journal Articles

Enhanced Expression of DNp73 Promotes Drug Resistance and Immune Evasion in Multiple Myeloma By Targeting the MYC and MYCN Pathways

Lanting Liu, Lugui Qiu, Zhen Yu, Mu Hao

Blood (2023) 142 (Supplement 1): 4661.

https://doi.org/10.1182/blood-2023-177606

Published: 2023

Journal Articles

A Novel Indirubin-3-Monoxime Derivative Functions As Regulator of Proteostasis Via Targeting TRIM28 in Multiple Myeloma

Teng Fang, Hao Sun, Xiyue Sun, Zhen Yu, Xiaoyu Zhang, Lanting Liu, Lixin Gong, Shiyi Xie, Mu Hao, Lugui Qiu

Blood (2023) 142 (Supplement 1): 6572.

https://doi.org/10.1182/blood-2023-180712

Published: 2023

Journal Articles

CRIP1 Involves the Pathogenesis of Multiple Myeloma Via Dual-Regulation of Proteasome and Autophagy

Zhen Yu, Peixia Tang, Zhenshu Xu, Lugui Qiu, Mu Hao

Blood (2023) 142 (Supplement 1): 6598.

https://doi.org/10.1182/blood-2023-179724

Published: 2023

Journal Articles

High Level of IL-16 Secreted By Non-GCB DLBCL Facilitates Tumor Growth Though the Tumor-Promoting and Immunosuppressive Tumor Microenvironment

Xuwen Guan, Teng Fang, Yi Wang, Wei Liu, Mu Hao, Lugui Qiu

Blood (2023) 142 (Supplement 1): 6080.

https://doi.org/10.1182/blood-2023-180840

Published: 2023

Journal Articles

Exosome Mirnas Profiling in Serum and Prognostic Evaluation in Patients with Multiple Myeloma

Teng Fang, Hao Sun, Mu Hao, Lugui Qiu

Blood (2022) 140 (Supplement 1): 12474–12475.

https://doi.org/10.1182/blood-2022-162902

Published: 2022

Journal Articles

Identifying the Cells of Origin and Risk-Stratification Strategy By Single-Cell Sequencing in Multiple Myeloma

Lixin Gong, Junqiang Lv, Lugui Qiu, Hao Sun, Mu Hao

Blood (2022) 140 (Supplement 1): 12473.

https://doi.org/10.1182/blood-2022-159485

Published: 2022

Journal Articles

Multiple Myeloma-Derived Mir-27b-3p Facilitates Tumor Progression Via Promoting Tumor Cell Proliferation and Immunosuppressive Microenvironment

Xiaojing Wei, Zhen Yu, Hao Sun, Lixin Gong, Lanting Liu, Teng Fang, Yi He, Tingyu Wang, Weiwei Sui, Yan Xu, Gang An, Xiaoke Ma, Lugui Qiu, Mu Hao

Blood (2022) 140 (Supplement 1): 7106–7107.

https://doi.org/10.1182/blood-2022-156759

Published: 2022

Journal Articles

Single-Cell Transcriptome Profiling Reveals Tumor Cell Heterogeneity and Immunosuppressive Microenvironment in Waldenström Macroglobulinemia

Hao Sun, Teng Fang, Tingyu Wang, Zhen Yu, Lixin Gong, Xiaojing Wei, Lugui Qiu, Mu Hao

Blood (2022) 140 (Supplement 1): 11872.

https://doi.org/10.1182/blood-2022-164483

Published: 2022

Journal Articles

Immune Profiling of MM Microenvironment at Single-Cell Resolution

Lixin Gong, Hao Sun, Junqiang Lv, Lugui Qiu, Mu Hao

Blood (2022) 140 (Supplement 1): 9976–9977.

https://doi.org/10.1182/blood-2022-162341

Published: 2022

NARROW

26S Proteasome Non-Atpase Subunit 3 (PSMD3/Rpn3) Is a Potential Therapeutic Target in Multiple Myeloma

Synergistic Induction of Senescence-Driven Immune Responses and Myeloma Cell Cytotoxicity By CDK4/6 Inhibitors and Daratumumab Combination Therapy

TENT5C As a Target of Chromatin Remodeler SMARCA2 Participates BTK Inhibitor Resistance in Mantle Cell Lymphoma By Regulating ATP Metabolism

Single-Cell RNA Analysis of Bone Marrow Mononuclear Cells Reveals Abnormal Activation of T Cells and Monocytes, and Identifies CD35 As a Novel Biomarker and Therapeutic Target in Waldenstrom Macroglobulinemia

Critical Roles of LILRB4 in Promoting PIM Kinase Mediated Cell Proliferation and Tumorigenesis in Multiple Myeloma

Genomic Evolution By Serial Single-Cell Sequencing Identifies High Tumor Expression of LYN As a Promoter of Resistance in Waldenstrom's Macroglobulinemia Undergoing Ibrutinib Monotherapy

Determination of MYD88 and CXCR4 Mutation for Clinical Detection and Their Significance in Waldenström Macroglobulinemia

A Novel Indirubin-3-Monoxime Derivative Enhance Immune Cell Mediated Cytotoxicity in Multiple Myeloma

Single-Cell Multi-Omics Analysis Reveals Heterogeneity of Malignant Plasma Cell during Progression of Multiple Myeloma

Clinical Implications of Residual Immunophenotypically Normal Plasma Cells within Bone Marrow at Various Disease Stages in Multiple Myeloma

TRIM28 Serves As a Key Regulator of Protein Homeostasis and Mediates Proteasome Inhibitor Resistance in Multiple Myeloma

Enhanced Expression of DNp73 Promotes Drug Resistance and Immune Evasion in Multiple Myeloma By Targeting the MYC and MYCN Pathways

A Novel Indirubin-3-Monoxime Derivative Functions As Regulator of Proteostasis Via Targeting TRIM28 in Multiple Myeloma

CRIP1 Involves the Pathogenesis of Multiple Myeloma Via Dual-Regulation of Proteasome and Autophagy

High Level of IL-16 Secreted By Non-GCB DLBCL Facilitates Tumor Growth Though the Tumor-Promoting and Immunosuppressive Tumor Microenvironment

Exosome Mirnas Profiling in Serum and Prognostic Evaluation in Patients with Multiple Myeloma

Identifying the Cells of Origin and Risk-Stratification Strategy By Single-Cell Sequencing in Multiple Myeloma

Multiple Myeloma-Derived Mir-27b-3p Facilitates Tumor Progression Via Promoting Tumor Cell Proliferation and Immunosuppressive Microenvironment

Single-Cell Transcriptome Profiling Reveals Tumor Cell Heterogeneity and Immunosuppressive Microenvironment in Waldenström Macroglobulinemia

Immune Profiling of MM Microenvironment at Single-Cell Resolution

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only